Novel DX logo

Novel DX Funding & Investors

Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics. Its device uses microfluidics to analyze a raw biological sample directly at the point of care and takes only 30 minutes to interpret quality results that enable healthcare professionals to achieve lab-quality results in a lab-free environment. The company was founded by Andrea Pais in 2014 and is headquartered in Baltimore, Maryland.

noveldx.com

Total Amount Raised: $15,200,000

Novel DX Funding Rounds

  • Grant

    $1,400,000

    Grant Investors

    National Institutes of Health (NIH)
  • Grant

    $13,800,000

    Grant Investors

    CARB-X
Funding info provided by Diffbot.